Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Oct 2, 2024
Dr. Boris Reznik, Chairman and CEO of Immorta Bio, was founded to explore longevity and life extension technologies inspired by the discovery that aged cells can be reprogrammed to become younger ones. The company has a cellular rejuvenation platform that uses the patient's cells and senolytic immunotherapy to help the immune system target and remove senescent cells. These approaches aim to leverage the body's natural mechanism for maintaining health and extending the healthspan, not just lifespan.
Boris explains, "First of all, let me just touch upon aging because aging perpetually happens on a cellular level from an early age because trillions of mutations occur in our cells every single day. But the young body’s defense mechanism, such as the immune system and stem cells, effectively addresses those issues and keeps young people healthy. So everything we do is associated with the approach where we try to use young bodies’ mechanisms in dealing with all diseases and all issues associated with aging."
"As I said, young bodies have mechanisms, but all mechanisms which body uses, they have a tendency to deteriorate with age, and it starts all on cellular level. They progress from cells to tissues, from tissues to organs, from organs to systems, and, eventually, all of that results in a disease. And those diseases are what we call diseases of aging. So, actually, the disease of aging is just a specific stage of aging. So, what we created and what we focus on are the two fundamental areas of longevity technologies."
#ImmortaBio #Longevity #StemCells #Cancer #Aging #Rejuvenation
